Repetitive transcranial magnetic stimulation plus standardized suggestion of benefit for functional movement disorders: An open label case series

Parkinsonism and Related Disorders

Volumn 21, Issue 4, 2015, Pages 407-412

  Shah, B B ^a   Chen, R ^b,c   Zurowski, M ^d   Kalia, L V ^b,c   Gunraj, C ^b,c   Lang, A E ^b,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Functional movement disorders; Psychogenic; Psychogenic movement disorders; Repetitive transcranial magnetic stimulation; Suggestion

Indexed keywords

ADULT; ARTICLE; BARBERS SUGGESTIBILITY SCALE; BASELINE EXPECTATION OF BENEFIT SCALE; BLINDED RUSH PSYCHOGENIC MOVEMENTS RATING SCALE; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FUNCTIONAL MOVEMENT DISORDER; GLOBAL IMPRESSION OF CHANGE; HEADACHE; HUMAN; MOTOR CORTEX; MOTOR DYSFUNCTION; OPEN STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PREMOTOR CORTEX; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SUGGESTION; TRANSCRANIAL MAGNETIC STIMULATION; WORLD HEALTH ORGANIZATION QUALITY OF LIFE BRIEF SCALE; CASE REPORT; FEMALE; MALE; MIDDLE AGED; MOVEMENT DISORDERS; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; SOMATOFORM DISORDERS;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; MOVEMENT DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; QUALITY OF LIFE; SOMATOFORM DISORDERS; SUGGESTION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84925368779     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.01.013     Document Type: Article

References (21)

1. Lang A.E. General overview of psychogenic movement disorders: epidemiology, diagnosis, and prognosis. Psychogenic movement disorders - neurology and neuropsychiatry 2006, 35-41. Lippincott Williams & Wilkins, Philadelphia. M. Hallett, S. Fahn, J. Jankovic, A.E. Lang, C.R. Cloninger, S.C. Yudofsky (Eds.).
2. Feinstein A., Stergiopoulos V., Fine J., Lang A.E. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Neuropsychiatry Neuropsychol Behav Neurol 2001, 14(3):169-176.
3. Pringsheim T., Chen R., Lang A.E. Psychogenic movement disorders. High-order motor disorders - from neuroanatomy and neurobiology to clinical neurology 2005, 397-412. Oxford University Press, Oxford. H.J. Freund, M. Jeannerod, M. Hallett, R. Leiguarda (Eds.).
4. Schonfeldt-Lecuona C., Connemann B.J., Viviani R., Spitzer M., Herwig U. Transcranial magnetic stimulation in motor conversion disorder: a short case series. JClin Neurophysiol 2006, 23(5):472-475.
5. Garcin B., Roze E., Mesrati F., Cognat E., Fournier E., Vidailhet M., et al. Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders. JNeurol Neurosurg Psychiatr 2013, 84(9):1043-1046.
6. Elahi B., Elahi B., Chen R. Effect of transcranial magnetic stimulation on parkinson motor function-systematic review of controlled clinical trials. Mov Disord 2009, 24(3):357-363.
7. Daskalakis Z.J., Levinson A.J., Fitzgerald P.B. Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can J Psychiatry 2008, 53(9):555-566.
8. Lam R.W., Chan P., Wilkins-Ho M., Yatham L.N. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry 2008, 53(9):621-631.
9. Burt T., Lisanby S.H., Sackeim H.A. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol 2002, 5(1):73-103.
10. Shamy M.C. The treatment of psychogenic movement disorders with suggestion is ethically justified. Mov Disord 2010, 25(3):260-264.
11. Pollak T.A., Nicholson T.R., Edwards M.J., David A.S. Asystematic review of transcranial magnetic stimulation in the treatment of functional (conversion) neurological symptoms. JNeurol Neurosurg Psychiatr 2014, 85:191-197.
12. Factor S.A., Podskalny G.D., Molho E.S. Psychogenic movement disorders: frequency, clinical profile, and characteristics. JNeurol Neurosurg Psychiatr 1995, 59(4):406-412.
13. Couprie W., Wijdicks E.F., Rooijmans H.G., van Gijn J. Outcome in conversion disorder: a follow up study. JNeurol Neurosurg Psychiatr 1995, 58(6):750-752.
14. Hinson V.K., Weinstein S., Bernard B., Leurgans S.E., Goetz C.G. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord 2006, 12(3):177-180.
15. Rossi S., Hallett M., Rossini P.M., Pascual-Leone A., Safety of TMS Consensus Group Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009, 120(12):2008-2039.
16. The world health organization quality of life assessment (WHOQOL): position paper from the world health organization. Soc Sci Med 1995, 41(10):1403-1409.
17. Guy W. ECDEU assessment manual for psychopharmacology 1976, National Institute of Mental Health, Rockville, Maryland.
18. Barber T.X. Measuring "hypnotic-like" suggestibility with and without "hypnotic induction"; psychometric properties, norms, and variables influencing response to the barber suggestibility scale (bss). Psychol Rep 1965, 16:809-844.
19. Bonomi A.E., Patrick D.L., Bushnell D.M., Martin M. Validation of the United States' version of the World Health Organization quality of life (WHOQOL) instrument. JClin Epidemiol 2000, 53(1):1-12.
20. Edwards M.J., Bhatia K.P., Cordivari C. Immediate response to botulinum toxin injections in patients with fixed dystonia. Mov Disord 2011, 26(5):917-918.
21. Hurwitz T.A. Somatization and conversion disorder. Can J Psychiatry 2004, 49:172-178.